COMPASS THERAPEUTICS, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $35.5M | $55.2M | $30.6M | $46.2M | $22.9M | $41.0M | $43.5M | $19.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $180.9M | $195.7M | $209.8M | $221.1M | $106.2M | $124.1M | $132.8M | $141.1M |
| Property, Plant & Equipment | $324.0K | $169.0K | $102.0K | $119.0K | $131.0K | $102.0K | $353.0K | $493.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $190.2M | $205.2M | $219.6M | $231.3M | $116.7M | $131.5M | $140.4M | $149.2M |
| Liabilities | ||||||||
| Accounts Payable | $2.9M | $906.0K | $1.6M | $3.1M | $2.6M | $1.6M | $2.2M | $960.0K |
| Total Current Liabilities | $16.1M | $10.3M | $14.0M | $12.4M | $13.9M | $14.9M | $8.9M | $4.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $24.1M | $18.7M | $22.8M | $21.6M | $23.5M | $21.2M | $15.2M | $10.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-474.6M | $-449.5M | $-431.2M | $-415.5M | $-401.2M | $-381.3M | $-364.7M | $-349.7M |
| Total Stockholders' Equity | $166.0M | $186.5M | $196.8M | $209.6M | $93.2M | $110.3M | $125.2M | $138.4M |